The global Sepsis Diagnostics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Sepsis Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sepsis Diagnostics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sepsis Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sepsis Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
bioMerieux SA
Cepheid
Thermo Fisher Scientific Inc.
Bacterial
T2 Biosystems, Inc.
Bruker Corporation
Beckman Coulter, Inc.
Nanosphere, Inc.
Abbott Laboratories, Inc.
Roche Diagnostics Limited
Becton, Dickinson and Company

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry

Segment by Application
Laboratory Testing
Point-of-care Testing